# Cingulate Inc.: filings

CING · Nasdaq · CIK 1862150 · [Healthcare](/sectors/healthcare.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/cing.md) · [Financials](/companies/cing/financials.md) · [Filings](/companies/cing/filings.md) · [Insiders](/companies/cing/insiders.md)

## Reports and events: 175 filings

Newest first, by EDGAR acceptance time (Eastern). Filter with ?form= one of: `periodic`, `8-K`, `10-K`, `10-Q`, `4`, `proxy`, `13dg`, `all`, or any form this company filed (4 152, 8-K 99, CORRESP 26, 3 23, SC 13D/A 21, EFFECT 16, UPLOAD 16, 10-Q 14, 424B3 12, S-1/A 12, DEF 14A 10, S-1 10, DEFA14A 8, PRE 14A 8, 424B4 7, 424B5 6, S-8 6, 10-K 5, S-3 5, SC 13G/A 5, ARS 4, POS AM 3, SC 13G 3, 8-A12B 2, CERT 2, DRS 2, DRS/A 2, DRSLTR 2, RW 2, SC 13D 2, SEC STAFF LETTER 2, D 1, NT 10-Q 1, POS EX 1, S-3/A 1, SCHEDULE 13D 1, SCHEDULE 13D/A 1).

| Filed | Accepted | Form | What it is | Accession |
| --- | --- | --- | --- | --- |
| 2026-10-02 | 20:30 ET | [8-K](/filings/0001493152-26-045527.md) | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001493152-26-045527 |
| 2026-08-13 | 12:45 ET | [10-Q](/filings/0001493152-26-037606.md) | Quarterly report, period 2026-06-30 | 0001493152-26-037606 |
| 2026-08-13 | 12:40 ET | [8-K](/filings/0001493152-26-037605.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001493152-26-037605 |
| 2026-07-23 | 20:05 ET | [8-K](/filings/0001493152-26-034402.md) | 5.02 Departure or appointment of officers or directors | 0001493152-26-034402 |
| 2026-07-14 | 12:00 ET | [8-K](/filings/0001493152-26-033115.md) | 5.02 Departure or appointment of officers or directors; 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0001493152-26-033115 |
| 2026-07-02 | 12:40 ET | [8-K](/filings/0001493152-26-031668.md) | 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001493152-26-031668 |
| 2026-06-16 | 12:10 ET | [8-K](/filings/0001493152-26-028815.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001493152-26-028815 |
| 2026-06-02 | 12:10 ET | [8-K](/filings/0001493152-26-026760.md) | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001493152-26-026760 |
| 2026-05-29 | 13:16 ET | [DEF 14A](/filings/0001493152-26-025721.md) | Proxy statement, period 2026-05-29 | 0001493152-26-025721 |
| 2026-05-19 | 20:50 ET | [8-K](/filings/0001493152-26-024435.md) | 5.02 Departure or appointment of officers or directors | 0001493152-26-024435 |
| 2026-05-14 | 12:15 ET | [10-Q](/filings/0001493152-26-022884.md) | Quarterly report, period 2026-03-31 | 0001493152-26-022884 |
| 2026-05-14 | 12:10 ET | [8-K](/filings/0001493152-26-022881.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001493152-26-022881 |
| 2026-04-02 | 20:05 ET | [8-K](/filings/0001493152-26-014914.md) | 5.02 Departure or appointment of officers or directors | 0001493152-26-014914 |
| 2026-03-26 | 20:24 ET | [SCHEDULE 13D/A](/filings/0001140361-26-011373.md) | Ownership report, active investor, amended | 0001140361-26-011373 |
| 2026-03-24 | 21:14 ET | [8-K](/filings/0001493152-26-012417.md) | 1.01 Entry into a material agreement; 5.07 Shareholder vote results | 0001493152-26-012417 |
| 2026-03-18 | 12:13 ET | [10-K](/filings/0001493152-26-010882.md) | Annual report, period 2025-12-31 | 0001493152-26-010882 |
| 2026-03-18 | 12:10 ET | [8-K](/filings/0001493152-26-010881.md) | 2.02 Results of operations; 8.01 Other events; 9.01 Financial statements and exhibits | 0001493152-26-010881 |
| 2026-03-02 | 12:00 ET | [DEF 14A](/filings/0001493152-26-008441.md) | Proxy statement, period 2026-03-02 | 0001493152-26-008441 |
| 2026-02-17 | 13:10 ET | [8-K](/filings/0001493152-26-006942.md) | 3.02 Unregistered sale of equity; 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001493152-26-006942 |
| 2026-02-09 | 21:00 ET | [SCHEDULE 13D](/filings/0001140361-26-004386.md) | Ownership report, active investor | 0001140361-26-004386 |
| 2026-02-06 | 21:12 ET | [8-K](/filings/0001493152-26-005561.md) | 3.02 Unregistered sale of equity; 8.01 Other events | 0001493152-26-005561 |
| 2026-01-28 | 21:10 ET | [8-K](/filings/0001493152-26-004030.md) | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 5.03 Amendment to articles or bylaws; 9.01 Financial statements and exhibits | 0001493152-26-004030 |
| 2026-01-15 | 21:05 ET | [8-K](/filings/0001493152-26-002417.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001493152-26-002417 |
| 2026-01-02 | 21:30 ET | [8-K](/filings/0001493152-26-000142.md) | 3.02 Unregistered sale of equity | 0001493152-26-000142 |
| 2025-12-15 | 14:14 ET | [8-K](/filings/0001493152-25-027667.md) | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001493152-25-027667 |
| 2025-11-13 | 22:07 ET | [10-Q](/filings/0001493152-25-022395.md) | Quarterly report, period 2025-09-30 | 0001493152-25-022395 |
| 2025-11-13 | 13:15 ET | [8-K](/filings/0001493152-25-022132.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001493152-25-022132 |
| 2025-11-10 | 13:17 ET | [8-K](/filings/0001493152-25-021410.md) | 1.01 Entry into a material agreement; 2.03 New direct financial obligation; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001493152-25-021410 |
| 2025-10-14 | 12:15 ET | [8-K](/filings/0001493152-25-017931.md) | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001493152-25-017931 |
| 2025-09-25 | 21:00 ET | [8-K](/filings/0001493152-25-014963.md) | 5.07 Shareholder vote results | 0001493152-25-014963 |
| 2025-09-05 | 21:00 ET | [8-K](/filings/0001493152-25-012753.md) | 3.02 Unregistered sale of equity | 0001493152-25-012753 |
| 2025-08-28 | 21:21 ET | [8-K](/filings/0001493152-25-012449.md) | 5.02 Departure or appointment of officers or directors | 0001493152-25-012449 |
| 2025-08-19 | 12:56 ET | [10-Q](/filings/0001641172-25-024744.md) | Quarterly report, period 2025-06-30 | 0001641172-25-024744 |
| 2025-08-19 | 12:50 ET | [8-K](/filings/0001641172-25-024741.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001641172-25-024741 |
| 2025-08-15 | 20:30 ET | [DEF 14A](/filings/0001641172-25-024386.md) | Proxy statement, period 2025-08-15 | 0001641172-25-024386 |
| 2025-08-15 | 13:08 ET | [8-K](/filings/0001641172-25-024286.md) | 5.02 Departure or appointment of officers or directors | 0001641172-25-024286 |
| 2025-08-08 | 11:00 ET | [8-K](/filings/0001641172-25-022664.md) | 5.02 Departure or appointment of officers or directors | 0001641172-25-022664 |
| 2025-08-06 | 12:50 ET | [8-K](/filings/0001641172-25-022360.md) | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001641172-25-022360 |
| 2025-07-25 | 20:28 ET | [S-1/A](/filings/0001641172-25-021016.md) | Registration statement, amended | 0001641172-25-021016 |
| 2025-07-25 | 20:05 ET | [8-K](/filings/0001641172-25-021006.md) | 3.02 Unregistered sale of equity | 0001641172-25-021006 |
| 2025-07-22 | 21:30 ET | [S-1](/filings/0001641172-25-020622.md) | Registration statement | 0001641172-25-020622 |
| 2025-07-22 | 21:15 ET | [8-K](/filings/0001641172-25-020618.md) | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 9.01 Financial statements and exhibits | 0001641172-25-020618 |
| 2025-06-11 | 11:00 ET | [8-K](/filings/0001641172-25-014621.md) | 5.02 Departure or appointment of officers or directors; 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0001641172-25-014621 |
| 2025-05-13 | 21:00 ET | [8-K](/filings/0001641172-25-009989.md) | 1.02 Termination of a material agreement | 0001641172-25-009989 |
| 2025-05-08 | 20:40 ET | [10-Q](/filings/0001641172-25-009289.md) | Quarterly report, period 2025-03-31 | 0001641172-25-009289 |
| 2025-05-08 | 20:35 ET | [8-K](/filings/0001641172-25-009286.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001641172-25-009286 |
| 2025-04-25 | 21:00 ET | [DEF 14A](/filings/0001641172-25-006260.md) | Proxy statement, period 2025-04-25 | 0001641172-25-006260 |
| 2025-04-09 | 12:13 ET | [8-K](/filings/0001641172-25-003329.md) | 1.01 Entry into a material agreement; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001641172-25-003329 |
| 2025-03-27 | 21:12 ET | [10-K](/filings/0001641172-25-000970.md) | Annual report, period 2024-12-31 | 0001641172-25-000970 |
| 2025-03-26 | 13:05 ET | [8-K](/filings/0001641172-25-000689.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001641172-25-000689 |

Page 1 of 4. [Older](/companies/cing/filings.md?page=2)
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Oct 24, 2026, 15:06 ET. No prices; not investment advice.